Real-time enrollment status for this kidney disease clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 9:28 AM UTC
| NCT Number | NCT05312879 |
| Recruiting Status | Recruiting |
| Condition | Kidney Disease |
| Phase | Clinical Trial |
| Target Enrollment | 466 participants |
| Active Locations | 225 sites in the US |
| Sponsor | Vertex Pharmaceuticals Incorporated |
| Last Updated on CT.gov | February 27, 2026 (3 days ago) |
As of March 2, 2026: Clinical trial NCT05312879 is currently recruiting participants. This clinical trial study for kidney disease is actively seeking new participants at 225 locations across the United States. The study is sponsored by Vertex Pharmaceuticals Incorporated. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05312879 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 225 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05312879 was last updated 3 days ago (February 27, 2026). HelloStudys verifies this status automatically.